| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/06/2013 | CN101623317B Serrate club moss oral disintegrating tablet and preparation method thereof |
| 03/06/2013 | CN101455654B Arginine ibuprofen gel and preparation method thereof |
| 03/06/2013 | CN101455653B Arginine ibuprofen oral disintegrating tablets and preparation method thereof |
| 03/06/2013 | CN101378733B Polymeric implant and a process for obtaining a polymeric implant |
| 03/06/2013 | CN101287411B Pharma-informatics system |
| 03/06/2013 | CN101217977B Thermoreversible immuno-adjuvant emulsion |
| 03/06/2013 | CN101108246B Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof |
| 03/06/2013 | CN101083977B Taste-masking pharmaceutical compositions |
| 03/05/2013 | US8389713 Polysaccharide pseudo-sponge |
| 03/05/2013 | US8389603 Thermal properties modified by powder size; whisker type fillers; drug delivery |
| 03/05/2013 | US8389502 Stabilized steroid composition and method for its preparation |
| 03/05/2013 | US8389495 Olioodeoxynucleotide and its use to induce an immune response |
| 03/05/2013 | US8389470 Methods and compositions for delivering peptides |
| 03/05/2013 | US8389467 In situ self-setting mineral-polymer hybrid materials, composition and use thereof |
| 03/05/2013 | US8389043 Preparation for restenosis prevention |
| 03/05/2013 | US8389017 Calcium-containing structures and methods of making and using the same |
| 03/05/2013 | US8389014 Gel useful for the delivery of ophthalmic drugs |
| 03/05/2013 | US8389013 Process for producing particles via atomized rapid injection for solvent extraction |
| 03/05/2013 | US8389012 Gellan-gum nanoparticles and methods of making and using the same |
| 03/05/2013 | US8389011 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/05/2013 | US8389009 Spatial control of signal transduction |
| 03/05/2013 | US8389008 Delayed release dosage forms |
| 03/05/2013 | US8389007 Pharmaceutical composition containing gelling agent |
| 03/05/2013 | US8389006 Pharmaceutical compositions of adsorbates of amorphous drug |
| 03/05/2013 | US8389005 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| 03/05/2013 | US8389004 Process for producing protein microparticles |
| 03/05/2013 | US8389003 Ingestible implement for weight control |
| 03/05/2013 | US8389002 Anti-cancer medicine both for diagnosing and treating cancer |
| 03/05/2013 | US8389001 Precursor composition for crosslinkable pressure-sensitive adhesive for skin |
| 03/05/2013 | US8389000 Adhesive skin patch and method for evaluation of adhesive skin patch |
| 03/05/2013 | US8388995 Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform |
| 03/05/2013 | US8388994 Fibrous non-woven polymeric material |
| 03/05/2013 | US8388991 Moisturizing antimicrobial composition |
| 03/05/2013 | US8388989 Articles of clothing treated with ammonia oxidizing bacteria to produce nitric oxide |
| 03/05/2013 | US8388985 Easily dispersible lipidic phase |
| 03/05/2013 | US8388984 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 03/05/2013 | US8388983 Film coatings containing fine particle size detackifiers and substrates coated therewith |
| 03/05/2013 | US8388982 Photo-induced damage mitigating agents and preparation and methods of use thereof |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 03/05/2013 | US8388966 Combination treatment of pancreatic cancer |
| 03/05/2013 | US8388945 Degradable microcapsules |
| 03/05/2013 | US8388941 Self preserved aqueous pharmaceutical compositions |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | US8388598 Method and device for controlling several infusion pumps |
| 03/05/2013 | CA2628031C Once-daily administration of central nervous system drugs |
| 03/05/2013 | CA2578250C Therapeutic composition with a botulinum neurotoxin |
| 03/05/2013 | CA2554695C Solid formulations of ospemifene |
| 03/05/2013 | CA2552004C Methods for tailoring the immune response to an antigen or immunogen |
| 03/05/2013 | CA2539033C Treatment of disease or injury of the nervous system with fty720 |
| 03/05/2013 | CA2528249C Orally-dispersible multilayer tablet |
| 03/05/2013 | CA2407614C Dried microorganism cell product by spray-drying |
| 03/01/2013 | WO2012027159A1 Policosanol nanoparticles |
| 03/01/2013 | CA2844073A1 Policosanol nanoparticles |
| 03/01/2013 | CA2751350A1 Adhesive patch and adhesive preparation |
| 02/28/2013 | WO2013029062A1 Peginterferon lambda 1 conjugates, processes for their preparation, pharmaceutical compositions containing these conjugates and processes for making the same |
| 02/28/2013 | WO2013028852A1 Systems, devices, methods, and admixtures of transponders and food products for indication of food attributes |
| 02/28/2013 | WO2013028756A1 Atom transfer radical polymerization under biologically compatible conditions |
| 02/28/2013 | WO2013028624A1 Compositions, devices, and methods for treating infections |
| 02/28/2013 | WO2013028333A1 Edible strips |
| 02/28/2013 | WO2013028177A1 Formulations of deoxycholic acid and salts thereof |
| 02/28/2013 | WO2013028153A2 Method and apparatus for removing noxious materials from cells |
| 02/28/2013 | WO2013028032A1 Preparation for percutaneous absorption and method for preparing same |
| 02/28/2013 | WO2013027840A1 Hydrous adhesive skin patch |
| 02/28/2013 | WO2013027681A1 Transdermal patch |
| 02/28/2013 | WO2013027150A1 Compositions and methods for the treatment of parkinson's disease |
| 02/28/2013 | WO2013027065A1 Ophthalmic formulations |
| 02/28/2013 | WO2013027052A1 A device for the transdermal delivery of alkaline compounds that are susceptible to degradation in their free base form |
| 02/28/2013 | WO2013026989A2 Liposome comprising at least one cholesterol derivative |
| 02/28/2013 | WO2013026772A1 Flurbiprofen and related compounds for the treatment of skin diseases |
| 02/28/2013 | WO2013026699A1 Method for preparing an aromatic composition including a compound containing two solids having organoleptic properties |
| 02/28/2013 | WO2013026694A1 Pharmaceutical compositions comprising voriconazole |
| 02/28/2013 | WO2013026553A1 Composition comprising edoxaban |
| 02/28/2013 | WO2013026547A1 Rotigotine in the treatment of hemispatial neglect and other deficits following stroke |
| 02/28/2013 | WO2013026487A1 Rigid moulded body for treating pruritus |
| 02/28/2013 | WO2013026270A1 Use of dexibuprofen levocetirizine double-layer sustained release tablet in treatment of airway inflammation |
| 02/28/2013 | WO2013026269A1 Method for preparing metered dose sprayed inhaler for treating respiratory disease |
| 02/28/2013 | WO2013026157A1 Anti-cancer peptides and uses thereof |
| 02/28/2013 | WO2013026117A1 Non-residual, pour-on veterinary compositions, use, kit, and method for treating parasitic diseases |
| 02/28/2013 | WO2013002479A3 Nanoemulsion composition and method for preparing same |
| 02/28/2013 | WO2012177935A8 Compositions and methods for the treatment of cancer |
| 02/28/2013 | WO2012176212A4 Carrier based nanogel formulation for skin targeting. |
| 02/28/2013 | WO2012167212A3 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current |
| 02/28/2013 | WO2012158960A3 Melanocortin 1 receptor ligands and methods of use |
| 02/28/2013 | WO2012151247A3 FORMULATION FOR ANTI-α4β7 ANTIBODY |
| 02/28/2013 | WO2012117385A3 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it |
| 02/28/2013 | WO2012013229A8 Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system. |
| 02/28/2013 | US20130053938 Surface protective and release matrices |
| 02/28/2013 | US20130053618 Radiation sensitive liposomes |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130052270 Use of Gold Nanoclusters in Ameliorating Oxidate Stress and/or Aging |
| 02/28/2013 | US20130052269 Formulations for oral delivery of adsorbents in the gut |
| 02/28/2013 | US20130052268 Compositions and methods for treatment of parkinson's disease |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052266 TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND |
| 02/28/2013 | US20130052265 Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment |
| 02/28/2013 | US20130052264 Controlled-release pharmaceutical composition including tamsulosin or pharmaceutically acceptable salts thereof, and oral formulation including the same |
| 02/28/2013 | US20130052263 Pharmaceutical compositions with synchronized solubilizer release |
| 02/28/2013 | US20130052262 Dabigatran etexilate-containing oral pharmaceutical composition |
| 02/28/2013 | US20130052261 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
| 02/28/2013 | US20130052260 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |